SPDR Series Trust - SPDR S&P Biotech ETF (BMV:XBI)
1,975.50
-29.50 (-1.47%)
At close: Oct 17, 2025
BMV:XBI Holdings Information
BMV:XBI is an equity ETF with a total of 136 individual holdings. The top holdings are CRISPR Therapeutics AG stock at 2.24%, Revolution Medicines at 2.05%, Ionis Pharmaceuticals at 1.93%, Insmed at 1.92%, and Exact Sciences at 1.89%.
Total Holdings
25
Top 10 Percentage
19.16%
Asset Class
Equity
ETF Category
Health Care
Assets
124.28B
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | CRSP | CRISPR Therapeutics AG | 2.24% |
2 | RVMD | Revolution Medicines, Inc. | 2.05% |
3 | IONS | Ionis Pharmaceuticals, Inc. | 1.93% |
4 | INSM | Insmed Incorporated | 1.92% |
5 | EXAS | Exact Sciences Corporation | 1.89% |
6 | UTHR | United Therapeutics Corporation | 1.85% |
7 | ABBV | AbbVie Inc. | 1.83% |
8 | AMGN | Amgen Inc. | 1.82% |
9 | VRTX | Vertex Pharmaceuticals Incorporated | 1.81% |
10 | NTRA | Natera, Inc. | 1.81% |
11 | MRNA | Moderna, Inc. | 1.81% |
12 | GILD | Gilead Sciences, Inc. | 1.80% |
13 | EXEL | Exelixis, Inc. | 1.76% |
14 | REGN | Regeneron Pharmaceuticals, Inc. | 1.76% |
15 | BBIO | BridgeBio Pharma, Inc. | 1.75% |
16 | RNA | Avidity Biosciences, Inc. | 1.75% |
17 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.74% |
18 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.73% |
19 | INCY | Incyte Corporation | 1.72% |
20 | ROIV | Roivant Sciences Ltd. | 1.70% |
21 | BIIB | Biogen Inc. | 1.70% |
22 | NBIX | Neurocrine Biosciences, Inc. | 1.68% |
23 | BMRN | BioMarin Pharmaceutical Inc. | 1.65% |
24 | TGTX | TG Therapeutics, Inc. | 1.55% |
25 | AKRO | Akero Therapeutics, Inc. | 1.53% |
As of Oct 17, 2025